MiR-34a regulates therapy resistance by targeting HDAC1 and HDAC7 in breast cancer

Authors

Mei-Yi Wu, George Washington University
Junjiang Fu, Luzhou Medical CollegeFollow
Xiuli Xiao, Luzhou Medical College
Jingbo Wu, Luzhou Medical College
Ray-Chang Wu, George Washington University

Document Type

Journal Article

Publication Date

11-29-2014

Journal

Cancer Letters

Volume

Volume 354, Issue 2

Inclusive Pages

311-319

DOI

10.1016/j.canlet.2014.08.031

APA Citation

Wu, M.Y., Fu, J., Xiao, X., Wu, J., Wu, R. (2014). MiR-34a regulates therapy resistance by targeting HDAC1 and HDAC7 in breast cancer. Cancer Letters, 354(2), 311-319.

Peer Reviewed

1